NYSE · NOVTU
Technology · Hardware, Equipment & Parts
$58.48
Down-$2.51 (-4.12%)
Updated Oct 9, 2026, 8:29 AM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · NOVTU
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 8, 2026
NOVTU closed at $58.48 after 21 trading sessions, down 4.26% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 8, 2026 | $60.17 | $60.17 | $57.85 | $58.48 | 533.79K |
| Oct 7, 2026 | $61.77 | $61.77 | $60.52 | $60.99 | 5.17K |
| Oct 6, 2026 | $64.41 | $64.41 | $64.41 | $64.41 | 337 |
| Oct 5, 2026 | $62.22 | $63.02 | $61.83 | $63.02 | 2.72K |
| Oct 2, 2026 | $61.95 | $63.56 | $61.95 | $62.92 | 107.32K |
| Oct 1, 2026 | $59.91 | $61.85 | $59.87 | $61.08 | 2.58K |
| Sep 30, 2026 | $60.455 | $61.19 | $60.455 | $60.74 | 21.21K |
| Sep 29, 2026 | $60.78 | $60.78 | $59.87 | $59.87 | 2.15K |
| Sep 28, 2026 | $60.39 | $60.75 | $60.17 | $60.49 | 102.42K |
| Sep 25, 2026 | $61.155 | $61.155 | $60.95 | $60.95 | 1.53K |
| Sep 24, 2026 | $60.51 | $60.825 | $59.455 | $60.43 | 7.25K |
| Sep 23, 2026 | $60.98 | $61.77 | $60.46 | $61.55 | 25.21K |
| Sep 22, 2026 | $59.04 | $61.35 | $59.04 | $60.61 | 736.71K |
| Sep 21, 2026 | $58.03 | $58.03 | $58.03 | $58.03 | 733.14 |
| Sep 18, 2026 | $57.44 | $57.44 | $56.695 | $57.43 | 4.35K |
| Sep 17, 2026 | $57.80 | $58.03 | $57.80 | $58.03 | 611 |
| Sep 16, 2026 | $59.16 | $59.16 | $56.57 | $57.03 | 9.05K |
| Sep 15, 2026 | $59.36 | $59.52 | $58.95 | $58.95 | 3.66K |
| Sep 14, 2026 | $66.96 | $66.96 | $59.74 | $59.86 | 7.44K |
| Sep 11, 2026 | $62.58 | $62.58 | $61.64 | $61.64 | 1.63K |
| Sep 10, 2026 | $60.78 | $61.15 | $60.77 | $61.08 | 1.42K |
The latest Smart Investors Daily articles mentioning NOVTU.
Company
Market Activity
Research & News
NOVTU research
Company profile and research snapshot.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 13, 2026 | Baird | Outperform | — |
| Mar 30, 2026 | Baird | Outperform | — |
| Aug 11, 2025 | Baird | Neutral | — |
| Mar 3, 2025 | Baird | Neutral | — |
| Nov 6, 2024 | Baird | Neutral | — |
No generated briefing is available yet.
Yahoo · Sep 29, 2026
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
Yahoo · Sep 19, 2026
Recent commentary on Novanta (NOVT) has focused on its revenue growth profile and projected demand pickup, with solid gross margins drawing new attention to how the stock’s recent returns compare with those fundamentals. Short term trading pressure has been clear, with the share price down 9.2% over the past week and 14.3% over 90 days. Yet Novanta’s year to date share price return of 19.8% and 1 year total shareholder return of 16.1% point to momentum that has cooled rather than...
Yahoo · Sep 19, 2026
In recent commentary, Novanta (NASDAQ:NOVT) has been highlighted for its multi-year annual revenue growth of 10.7% and a gross margin of 44.4%, reflecting perceived market share gains and strong product positioning. This attention centers on Novanta’s combination of demand acceleration expectations and high-margin products, which analysts view as evidence of superior competitive capabilities. Next, we will examine how this focus on Novanta’s revenue momentum and margins may influence the...
Yahoo · Sep 18, 2026
“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning NOVTU.
